BIOAGE

$80$125

BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases. They have built a systems biology platform to map out the key molecular pathways that impact healthy human aging, based on proprietary human aging cohorts that have blood samples collected up to 45 years ago with participant -omics data that is tied to detailed medical follow-up records over their lifespan.

Report ID:

UMHE21741

Published:

Jan-2022

Pages:

12

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21741 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Value
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    Competitors
8.    Executive Team
9.   SWOT Analysis
10. Recent Development
10.1 Partnership
10.2 Business Expansions & Investments”

Companies Mentioned

“Neuromore
Rightangled
iamYiam
Shivom